{"id":"intravenous-methylene-blue-administration","safety":{"commonSideEffects":[{"rate":null,"effect":"Blue discoloration of urine and skin"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Serotonin syndrome (rare, with serotonergic agents)"}]},"_chembl":{"chemblId":"CHEMBL550495","moleculeType":"Small molecule","molecularWeight":"373.91"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylene blue functions as an electron carrier in mitochondrial respiration, enhancing ATP production and reducing reactive oxygen species. It also inhibits monoamine oxidase and has anti-inflammatory properties, making it potentially useful in conditions involving mitochondrial dysfunction and oxidative stress-related pathology.","oneSentence":"Methylene blue acts as a redox agent and monoamine oxidase inhibitor that reduces oxidative stress and modulates mitochondrial function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:48.310Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vasoplegic syndrome (phase 3)"},{"name":"Septic shock with vasodilation"}]},"trialDetails":[{"nctId":"NCT06052956","phase":"PHASE2","title":"Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-07-15","conditions":"Abscess","enrollment":120},{"nctId":"NCT07150819","phase":"NA","title":"A Multidisciplinary Perioperative Pain Management","status":"WITHDRAWN","sponsor":"China-Japan Friendship Hospital","startDate":"2022-07-01","conditions":"Anorectal Surgery, Pain Management","enrollment":""},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT07169487","phase":"PHASE1","title":"Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-06-28","conditions":"Cytokine Release Syndrome, ICANS","enrollment":18},{"nctId":"NCT04529265","phase":"NA","title":"Methylene Blue and Postoperative Neurocognitive Disorders","status":"COMPLETED","sponsor":"Fudan University","startDate":"2021-05-01","conditions":"Postoperative Delirium","enrollment":314},{"nctId":"NCT06015165","phase":"NA","title":"Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery","status":"RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2024-09-10","conditions":"Postoperative Pain","enrollment":216},{"nctId":"NCT04054999","phase":"PHASE4","title":"Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-11-30","conditions":"Vasoplegic Syndrome, Liver Transplant; Complications","enrollment":19},{"nctId":"NCT05812521","phase":"NA","title":"Thoracic Paravertebral Block With Methylene Blue Visual Confirmation for Postoperative Pain After VATS Lobectomy","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2020-01-15","conditions":"Post Operative Pain, Thoracic Cancer","enrollment":120},{"nctId":"NCT04547127","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2020-04-29","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04341844","phase":"NA","title":"Intraoperative Infusion of Methylene Blue for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery","status":"COMPLETED","sponsor":"Fudan University","startDate":"2019-01-14","conditions":"Postoperative Delirium, Postoperative Cognitive Dysfunction","enrollment":248},{"nctId":"NCT03446599","phase":"PHASE2","title":"Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery","status":"WITHDRAWN","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2019-11","conditions":"Vasoplegia, Hypotension, Coronary Artery Disease","enrollment":""},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT03120637","phase":"PHASE4","title":"Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2017-01-01","conditions":"Septic Shock, Vasoplegia, Cirrhosis, Liver","enrollment":111},{"nctId":"NCT03177070","phase":"PHASE2","title":"Fluorescent Imaging & Methylene Blue: Ureter Study","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-05-09","conditions":"Ureteric Injury, Surgery, Surgery--Complications","enrollment":50},{"nctId":"NCT01797978","phase":"PHASE3","title":"Methylene Blue in Severe Sepsis and Septic Shock","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2013-02","conditions":"Severe Sepsis, Septic Shock","enrollment":354}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["methylene blue administration","MB administration"],"phase":"phase_3","status":"active","brandName":"Intravenous methylene blue administration","genericName":"Intravenous methylene blue administration","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylene blue acts as a redox agent and monoamine oxidase inhibitor that reduces oxidative stress and modulates mitochondrial function. Used for Vasoplegic syndrome (phase 3), Septic shock with vasodilation.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}